Inasmuch as HSP has said nothing in more than a year about its ANDA for the vial formulation of Lovenox (#msg-34826629), I presume that the company does not consider this a material program.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”